<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>43(1)</volume><submitter>Bajpai P</submitter><journal>Journal of experimental &amp; clinical cancer research : CR</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11238352</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer</pubmed_title><pmcid>PMC11238352</pmcid><pubmed_authors>Manne U</pubmed_authors><pubmed_authors>Chandrashekar D</pubmed_authors><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Agarwal S</pubmed_authors><pubmed_authors>Paluri R</pubmed_authors><pubmed_authors>Afaq F</pubmed_authors><pubmed_authors>Al Diffalha S</pubmed_authors><pubmed_authors>Manne A</pubmed_authors><pubmed_authors>Khushman M</pubmed_authors><pubmed_authors>Shelton A</pubmed_authors><pubmed_authors>Miller C</pubmed_authors><pubmed_authors>Singh R</pubmed_authors><pubmed_authors>Nagaraju G</pubmed_authors><pubmed_authors>Singh S</pubmed_authors><pubmed_authors>Bajpai P</pubmed_authors><pubmed_authors>Varambally S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2025-04-05T15:48:13.788Z</modification><creation>2025-04-05T15:48:13.788Z</creation></dates><accession>S-EPMC11238352</accession><cross_references/></HashMap>